topotecan has been researched along with Meningeal Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Capra, M; Chew, S; Daly, P; Gleeson, JP; Grant, C; McCarthy, A; McDermott, M; Nicholson, S; O'Dwyer, R; Owens, C; Watson, GA | 1 |
| Anderson, SK; Colon-Otero, G; Dixon, JG; Hebenstreit, K; Jaeckle, KA; Moreno-Aspitia, A; Patel, TA; Perez, EA; Reddy, SL | 1 |
| Erdreich-Epstein, A; Finlay, JL; Hawes, D; Hoang, TQ; Mahdi, MY; Meng, EF; Moats, RA; Shackleford, GM; Tran, HC | 1 |
| Finlay, JL; Gardner, S; Liebes, LF; Tran, HC; Weiner, HL | 1 |
| de Groot, J; Kamiya-Matsuoka, C; Liao, B; Mella, DB; Tummala, S | 1 |
| Busse, PM; Ebb, DH; Friedmann, AM; Ladra, MM; Lucas, JT; MacDonald, SM; Marcus, KJ; Tarbell, NJ; Yock, TI | 1 |
| Anderson, JR; Arndt, CA; Donaldson, SS; Hawkins, DS; Lyden, ER; Morris, CD; Rodeberg, DA; Wolden, SL | 1 |
| Adamson, PC; Berg, S; Blaney, SM; Ingle, AM; Krailo, M; Potter, SL | 1 |
| Adamson, P; Balis, FM; Berg, S; Blaney, SM; Cole, D; Geyer, JR; Gillespie, A; Heideman, R; Jaeckle, K; Kuttesch, N; Matthay, K; Packer, R; Poplack, DG | 1 |
| Pavlidis, N; Pentheroudakis, G | 1 |
| Chuansumrit, A; Hongeng, S; Pakakasama, S; Sirachainan, N; Tuntiyatorn, L; Visudtibhan, A | 1 |
| Benvenuti, M; Bhatt, MS; Gammon, DC; Glantz, MJ; Tran, L; Van Horn, A | 1 |
| Baumgartner, KE; Chamberlain, MC; Colman, H; Conrad, CA; Forman, AD; Gilbert, MR; Glantz, MJ; Groves, MD; Hess, KR; Hsu, S; Hunter, KU; Ictech, S; Puduvalli, VK; Wefel, JS; Yung, WK | 1 |
1 review(s) available for topotecan and Meningeal Neoplasms
| Article | Year |
|---|---|
Management of leptomeningeal malignancy.
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arachnoid Cysts; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Delayed-Action Preparations; Enzyme Inhibitors; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Palliative Care; Randomized Controlled Trials as Topic; Thiotepa; Topoisomerase I Inhibitors; Topotecan | 2005 |
4 trial(s) available for topotecan and Meningeal Neoplasms
| Article | Year |
|---|---|
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Female; Humans; Infant; Lymph Nodes; Male; Meningeal Neoplasms; Radiotherapy Dosage; Retroperitoneal Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topotecan; Treatment Failure; Tumor Burden; Vincristine | 2015 |
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Spinal; Leukemia; Male; Meningeal Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Topoisomerase I Inhibitors; Topotecan; Young Adult | 2012 |
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Middle Aged; Topotecan | 2003 |
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Middle Aged; Prognosis; Topotecan | 2008 |
8 other study(ies) available for topotecan and Meningeal Neoplasms
| Article | Year |
|---|---|
Leptomeningeal Relapse of Embryonal Rhabdomyosarcoma after 15 years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child, Preschool; Cyclophosphamide; Ear Neoplasms; Humans; Male; Meningeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy Dosage; Rare Diseases; Rhabdomyosarcoma, Embryonal; Time Factors; Topotecan; Treatment Outcome; Young Adult | 2020 |
Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Infusions, Intraventricular; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Progression-Free Survival; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Topoisomerase I Inhibitors; Topotecan | 2020 |
Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.
Topics: Animals; Cell Line, Tumor; Female; Humans; Infusions, Intraventricular; Injections, Intraventricular; Medulloblastoma; Meningeal Neoplasms; Meninges; Mice; Mice, Transgenic; Survival Analysis; Time Factors; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Cerebellar Neoplasms; Ependymoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningeal Neoplasms; Neoplasm Recurrence, Local; Pilot Projects; Topotecan; Treatment Outcome; Young Adult | 2014 |
Recurrent encephaloclastic cyst induced by intraventricular topotecan.
Topics: Aged; Brain; Cysts; Drug Delivery Systems; Female; Humans; Injections, Intraventricular; Magnetic Resonance Imaging; Meningeal Neoplasms; Recurrence; Topotecan | 2015 |
Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Nasal Cavity; Nose Neoplasms; Proton Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Retrospective Studies; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2015 |
Favorable response of intraommaya topotecan for leptomeningeal metastasis of neuroblastoma after intravenous route failure.
Topics: Antineoplastic Agents; Catheters, Indwelling; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Humans; Infusions, Intravenous; Injections, Spinal; Male; Meningeal Neoplasms; Neuroblastoma; Topoisomerase I Inhibitors; Topotecan | 2008 |
Intrathecal topotecan in adult patients with neoplastic meningitis.
Topics: Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Injections, Spinal; Male; Medical Audit; Meningeal Neoplasms; Middle Aged; Retrospective Studies; Topotecan; Treatment Outcome | 2006 |